Health care stocks rose Thursday afternoon, with the NYSE Health Care Index adding 1.4% and the Health Care Select Sector SPDR Fund (XLV) climbing 1.3%.
The iShares Biotechnology ETF (IBB) advanced 1.4%.
In corporate news, Alterity Therapeutics (ATHE) shares surged past 51% after the company said its ATH434 lead candidate demonstrated 48% slowing of clinical progression in a phase 2 trial in people with early-stage multiple system atrophy.
Tectonic Therapeutic (TECX) shares soared 94% after it said a phase 1b trial showed that TX45 improved left ventricular function and pulmonary hemodynamics.
Cigna (CI) shares fell 8.1% after it reported a decline in Q4 adjusted earnings, which also missed market expectations.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。